CVI Holdings’s Gossamer Bio GOSS Stock Holding History

CVI Holdings’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-976,108	Closed	-$813K	–	196
2023 Q3	$813K	Buy	+976,108	New	+$1.12M	1.61%	21

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

CVI Holdings's GOSS Position: Q4 2023 in Review

CVI Holdings sold out of Gossamer Bio (GOSS) in Q4 2023, closing a stake of 976,108 shares — an estimated $813K sold.

CVI Holdings first reported a position in GOSS in Q3 2023 and held it in 1 quarter. The position peaked at $813K in Q3 2023. 98 funds tracked by Wall St. Rank hold GOSS as of Q4 2023.

CVI Holdings reported no remaining Gossamer Bio position as of Q4 2023 after selling out during the quarter.
CVI Holdings sold 976,108 Gossamer Bio shares in Q4 2023, an estimated $813K.
CVI Holdings first reported a position in Gossamer Bio in Q3 2023 and held it in 1 quarter.
CVI Holdings's Gossamer Bio position peaked at $813K in Q3 2023.
98 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2023.

Based on CVI Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.